Arrowhead Pharmaceuticals, Inc (ARWR) Stock Price

69.33 ▲ +0.21 (+0.30%)
Open: 70.15 Vol: 3.76M Day's range: 67.835 - 72.00 Jan 30, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ARWR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 70.24▼ 69.92▼ 69.57▼ 67.55▲ 66.51▲
MA10 70.36▼ 69.38▼ 69.28▲ 67.11▲ 65.51▲
MA20 70.28▼ 69.11▲ 68.10▲ 66.62▲ 51.41▲
MA50 69.53▼ 67.89▲ 68.08▲ 63.19▲ 30.72▲
MA100 69.34▼ 68.07▲ 66.96▲ 49.65▲ 26.90▲
MA200 68.29▲ 67.01▲ 67.20▲ 33.25▲ 30.20▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.138▼ 0.060▲ 0.185▲ -0.118▼ 0.894▲
RSI 37.417▼ 54.555▲ 56.680▲ 58.064▲ 77.399▲
STOCH 54.642     64.191     50.513     60.089     76.755    
WILL %R -95.808▼ -58.427     -40.388     -25.797     -18.715▲
CCI -312.373▼ 62.230     91.340     144.592▲ 64.942    
Latest Filters Detected On ARWR
MA $ARWR Price Crossed Above MA(26) Set Alert
MA $ARWR Price Crossed Above MA(13) Set Alert
MA $ARWR Price Crossed Above MA(7) Set Alert
Arrowhead Pharmaceuticals, Inc News
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
Tuesday, January 27, 2026 03:32 AM
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi ...
Piper Sandler highlights Arrowhead Pharmaceuticals, Inc. (ARWR) pipeline with upcoming phase III hypertriglyceridemia data
Thursday, January 22, 2026 12:20 AM
We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. Arrowhead Pharmaceuticals, Inc. is among the best high growth stocks. TheFly reported on January 13 that Piper Sandler lifted ...
Arrowhead Pharmaceuticals (ARWR) Price Target Increased by 17.24% to 59.24
Saturday, December 06, 2025 12:56 PM
The average one-year price target for Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been revised to $59.24 / share. This is an increase of 17.24% from the prior estimate of $50.53 dated November 14, ...
ARWR historical stock data
date open high low close volume
30/01/26 70.15 72.00 67.835 69.33 3,756,806
29/01/26 65.58 69.85 65.4501 69.12 2,013,419
28/01/26 66.91 67.53 65.475 65.58 2,060,659
27/01/26 66.65 68.7999 66.29 66.91 1,229,892
26/01/26 66.50 67.6899 65.65 66.82 1,620,378
23/01/26 69.25 71.16 66.85 67.05 1,930,448
22/01/26 68.95 71.14 68.17 69.59 2,672,616
21/01/26 65.76 69.00 65.23 67.60 1,548,112
20/01/26 62.00 65.33 61.65 65.28 1,415,353
16/01/26 66.45 66.7315 63.69 63.84 1,567,812
Quote Details
52wk Low:9.57
52wk High:76.76
Vol:3.76M
Avg Vol(3m):54.5M
1Y Chng:+239.19%
1M Chng:+6.99%
Add to Watch List
More Information
Index US Composite
Market Cap. 9.71B